Mechanistically, HINT2 enhanced SIRT3 activity by upregulating solute carrier family 25 member 51 (SLC25A51) to facilitate NAD+ efflux, thereby attenuating mitochondrial injury and ameliorating MASLD. The gene discussed is SIRT3; the disease is metabolic dysfunction-associated steatotic liver disease.